BIRC2 and osteosarcoma: As members of the anti-apoptotic family of proteins, IAP molecules, such as cIAP-1 and XIAP, play important roles in modulating the inactivation of apoptosis and correlate with a poor prognosis and resistance to chemotherapy in osteosarcoma [14,15,16].